HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyaloideoretinal degeneration of Wagner

Wgn1 not included
Also Known As:
Erosive vitreoretinopathy; Vcan-Related Vitreoretinopathy; Wagner Disease; Wagner Syndrome; Wagner Syndrome 1; Wagner syndrome type 1; Wagner vitreoretinal degeneration
Networked: 14 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Hyaloideoretinal degeneration of Wagner
2. Retinal Detachment (Retinal Detachments)
3. Cataract (Cataracts)
4. Uveitis
5. Atrophy

Experts

1. Brézin, Antoine P: 3 articles (11/2015 - 01/2013)
2. Nedelec, Brigitte: 3 articles (11/2015 - 01/2013)
3. Valleix, Sophie: 3 articles (11/2015 - 01/2013)
4. Audo, Isabelle: 2 articles (11/2015 - 06/2013)
5. Ghiotti, Tiffany: 2 articles (06/2013 - 01/2013)
6. Rothschild, Pierre-Raphaël: 2 articles (06/2013 - 01/2013)
7. Metlapally, Ravikanth: 2 articles (01/2013 - 11/2009)
8. Tran-Viet, Khanh-Nhat: 2 articles (01/2013 - 11/2009)
9. Young, Terri L: 2 articles (01/2013 - 11/2009)
10. Burin-des-Roziers, Cyril: 1 article (11/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hyaloideoretinal degeneration of Wagner:
1. Versicans (Versican)IBA
2. Retinaldehyde (Retinal)IBA
3. Protein Isoforms (Isoforms)IBA
4. Retinal Pigments (Pigments, Visual)IBA
5. Chondroitin Sulfate ProteoglycansIBA
6. RNA IsoformsIBA
7. Collagen Type II (Type II Collagen)IBA
8. RNA Splice SitesIBA
9. Potassium Channels (Potassium Channel)IBA
10. Proteoglycans (Proteoglycan)IBA

Therapies and Procedures

1. Traction